Pharsight

Altathera Pharms Llc patents expiration

1. Sotalol Hydrochloride patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10512620 ALTATHERA PHARMS LLC Method of initiating and escalating sotalol hydrochloride dosing
Aug, 2038

(14 years from now)

US11696902 ALTATHERA PHARMS LLC Method of initiating and escalating sotalol hydrochloride dosing
Aug, 2038

(14 years from now)

US10799138 ALTATHERA PHARMS LLC Method of administering sotalol IV/switch
Apr, 2039

(15 years from now)

US11583216 ALTATHERA PHARMS LLC Method of administering sotalol IV/switch
Aug, 2039

(15 years from now)

Drugs and Companies using SOTALOL HYDROCHLORIDE ingredient

Market Authorisation Date: 02 July, 2009

Treatment: Dosing regimen for intravenous sotalol for administration in a facility that can provide continuous electrocardiographic monitoring and cardiac resuscitation.; Use for loading dose in patients with sy...

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

SOTALOL HYDROCHLORIDE family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic